🇺🇸 Adjuvant Epirubicin+ Cyclophosphamide in United States

Adjuvant Epirubicin+ Cyclophosphamide (adjuvant-epirubicin-cyclophosphamide) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Adjuvant Epirubicin+ Cyclophosphamide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Adjuvant Epirubicin+ Cyclophosphamide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Adjuvant Epirubicin+ Cyclophosphamide in United States?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.